Searchable abstracts of presentations at key conferences in endocrinology

ea0084op-03-13 | Oral Session 3: Advanced Thyroid Cancer | ETA2022

Thyroid cancer relapse as a challenge to a surgeon: The efficacy of radioguided occult lesion localization (roll) technique

Czarniecka Agnieszka , Wozniak Grzegorz , Zeman Marcin , Kalemba Michal , Wygoda Zbigniew , Chmielik Ewa , Stobiecka Ewa , J. Cortez Alexander , Krajewska Jolanta , Handkiewicz-Junak Daria

Introduction: Reoperation due to recurrent or persistent thyroid cancer (TC) poses a real challenge to a surgeon who must properly estimate the benefit risk-ratio. Radioguided occult lesion localization (ROLL) technique may facilitate the localization and sufficient and safe removal of nonpalpable TC relapse.Aim: To analyze the efficacy of the ROLL technique in reoperation of TC relapse.Material and methods: A retrospective study o...

ea0092ps1-06-03 | Thyroid Cancer clinical 1 | ETA2023

Clinical and surgical challenges of local relapse of papillary thyroid carcinoma (PTC)

Czarniecka Agnieszka , Wozniak Grzegorz , Zeman Marcin , Cortez Alexander J. , Stobiecka Ewa , Chmielik Ewa , Oczko-Wojciechowska Malgorzata , Krajewska Jolanta , Handkiewicz-Junak Daria

Aim: The assessment of the disease course and selected clinicopathological factors associated with recurrence risk and the effectiveness of surgical treatment of PTC patients.Material and Methods: The retrospective analysis of 260 PTC patients selected from 403 patients operated on for recurrent thyroid cancer between 2002 and 2018 was performed. All statistical analyses were done using the programming environment R (v. 4.0.2).Resu...

ea0063p421 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

RET Y791F carriers’ medical history – experience from one center

Hasse-Lazar Kornelia , Kotecka-Blicharz Agnieszka , Oczko-Wojciechowska Małgorzata , Pawlaczek Agnieszka , Michalik Barbara , Gawlik Tomasz , Jurecka-Lubieniecka Beata , Krajewska Jolanta , Krol Aleksandra , Legutko Marta , Czarniecka Agnieszka , Zeman Marcin , Jarzęb Barbara

Introduction: Germline mutations of RET oncogene result in development of multiple endocrine neoplasia type 2 (MEN 2). There is a strong correlation between type of the RET sequence changes and the aggressiveness of main syndrome feature, medullary thyroid carcinoma (MTC), and the incidence of remaining manifestations, mainly pheochromocytoma (PHEO). For many of the RET germline mutations, the clinical risk have been precisely defined, but there are ...